Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-0.34%
-0.64%
-1.11%
+18.19%
Most Trending
-0.34%
-0.64%
-1.11%
+18.19%
12 Sep 2025$BABA Alibaba experienced a remarkable surge, jumping 6.35% in Hong Kong trading as the Chinese e-commerce giant announced aggressive AI expansion plans rivaling NVIDIA capabilities. The company's $53 billion three-year investment commitment in artificial intelligence and related technologies, combined with a $3.2 billion bond raise with 80% of proceeds earmarked for data center expansion, has reinvigorated investor confidence. Alibaba's Cloud Intelligence Group already shows strong momentum with 26% revenue growth, positioning the company at the forefront of China's AI revolution with massive upside potential.
$SRAD Sportradar Group earned initiation coverage from Roth/MKM with a Buy rating and ambitious $40 price target, representing over 30% upside potential from current levels around $30. The sports data and betting technology provider is well-positioned to capitalize on the global expansion of sports betting and the increasing digitization of sports entertainment. With trading volume below average, any positive momentum could drive significant price appreciation as institutional investors take notice.
$TVTX Travere Therapeutics earned a Buy rating based on the expansion potential of Filspari towards FSGS treatment, though the stock declined 6.12% despite the positive analyst action. The rare disease-focused biopharmaceutical company represents a compelling contrarian opportunity for investors willing to navigate biotech volatility, as the sell-off may have created an attractive entry point given the strong fundamental thesis around Filspari's market expansion potential.
$TBPH Theravance Biopharma gained momentum with B. Riley Securities analyst Mayank Mamtani initiating coverage with a Buy rating and $28 price target, representing nearly 100% upside from current levels around $14.30. The stock already jumped 4.38% on the upgrade news with trading volume significantly above average, suggesting strong institutional interest. The biotechnology company's pipeline developments and potential therapeutic breakthroughs continue to attract analyst attention in the competitive biotech space.
$GENI Genius Sports caught the attention of Roth/MKM analysts who initiated coverage with a Buy rating and $16 price target, offering approximately 30% upside from current levels around $12.48. The sports data and technology company stands to benefit from the continued expansion of sports betting and the growing demand for real-time sports analytics across multiple platforms and leagues. With trading volume well below average, any catalyst could drive rapid price movement.
Bottom line - TBPH offers the most explosive near-term opportunity with nearly 100% upside potential to its $28 price target, while BABA presents the strongest fundamental case with its massive AI investment and already proven momentum, making both attractive plays for traders seeking significant short-term gains.
September 11, 2025 08:59 PM
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
TopRated
